89007-52-3

2-Methoxy-6-(piperazin-1-yl)pyrazine can be used as potential mGlu5 receptor modulators to treat and/or prevent psychiatric disorders associated with glutamate dysfunction such as schizophrenia or cognitive decline such as dementia or cognitive impairment.